Results 31 to 40 of about 37,528 (237)

More than a Tripledemic: Influenza A Virus, Respiratory Syncytial Virus, SARS-CoV-2, and Human Metapneumovirus in Wastewater during Winter 2022–2023

open access: yesEnvironmental Science and Technology Letters, 2023
Wastewater monitoring can provide insights into respiratory disease occurrence in communities that contribute to the wastewater system. Using daily measurements of RNA of influenza A (IAV), respiratory syncytial virus (RSV), and human metapneumovirus ...
A. Boehm   +5 more
semanticscholar   +1 more source

Incidence of viral respiratory infections in a prospective cohort of outpatient and hospitalized children aged ≤5 years and its associated cost in Buenos Aires, Argentina [PDF]

open access: yes, 2015
Background: Although information about the incidence of viral respiratory illnesses and their associated cost can help health officials explore the value of interventions, data are limited from middle-income countries.
Azziz Baumgartner, Eduardo   +6 more
core   +1 more source

Avian Metapneumovirus Review: A Focus on Broilers [PDF]

open access: yesPoultry Science Journal, 2023
Avian Metapneumovirus infection first emerged in South African turkeys, followed by respiratory problems in chickens with a swollen head syndrome. The etiological agent is a Metapneumovirus in the Pneumoviridae family and the first pneumovirus identified
Amine Mernizi   +6 more
doaj   +1 more source

The emergence, impact, and evolution of human metapneumovirus variants from 2014 to 2021 in Spain.

open access: yesJournal of Infection, 2023
BACKGROUND Human metapneumovirus (HMPV) is an important aetiologic agent of respiratory tract infection (RTI). This study aimed to describe the prevalence, genetic diversity, and evolutionary dynamics of HMPV.
M. Piñana   +14 more
semanticscholar   +1 more source

Human metapneumovirus: Mechanisms and molecular targets used by the virus to avoid the immune system [PDF]

open access: yes, 2018
Indexación: Scopus.This work was supported by Comisión Nacional de Investigación Científica y Tecnolígica (CONICYT) N◦21151028 and FONDECYT (N◦1070352 and N◦1170964) and the Millennium Institute on Immunology and Immunotherapy (P09/016-F).Human ...
Benavente, F.M.   +8 more
core   +1 more source

Small Hydrophobic Protein of Human Metapneumovirus Does Not Affect Virus Replication and Host Gene Expression In Vitro [PDF]

open access: yes, 2013
Human metapneumovirus (HMPV) encodes a small hydrophobic (SH) protein of unknown function. HMPV from which the SH open reading frame was deleted (HMPVΔSH) was viable and displayed similar replication kinetics, cytopathic effect and plaque size compared ...
Aarbiou, J. (Jamil)   +12 more
core   +12 more sources

Neutralising antibodies against human metapneumovirus.

open access: yesThe Lancet Microbe, 2023
Human metapneumovirus (hMPV) is one of the leading causes of respiratory infection. Since its discovery in 2001, no specific antiviral or vaccine has been available in contrast to its closely related family member human respiratory syncytial virus (hRSV).
Lei Guo   +4 more
semanticscholar   +1 more source

Viruses associated with pneumonia in adults. [PDF]

open access: yes, 2012
Viral pneumonia, which is typically associated with disease in childhood, is increasingly recognized as causing problems in adults. Certain viruses, such as influenza virus, can attack fully immunocompetent adults, but many viruses take advantage of more-
Cesario, Thomas C
core   +1 more source

Structural basis for respiratory syncytial virus and human metapneumovirus neutralization.

open access: yesCurrent Opinion in Virology, 2023
Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) continue to be a global burden to infants, the elderly, and immunocompromised individuals.
Rose J. Miller, J. Mousa
semanticscholar   +1 more source

COPD Is Associated with Elevated IFN-β Production by Bronchial Epithelial Cells Infected with RSV or hMPV

open access: yesViruses, 2021
IFN treatment may be a viable option for treating COPD exacerbations based on evidence of IFN deficiency in COPD. However, in vitro studies have used primarily influenza and rhinoviruses to investigate IFN responses.
Natasha Collinson   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy